A Phase 3, Multicenter, Open-Label, Uncontrolled Study to Evaluate the Efficacy and Safety of Cx601 in the Treatment of Complex Perianal Fistulas in Adult Patients With Crohn's Disease
Phase of Trial: Phase III
Latest Information Update: 05 Dec 2019
Price : $35 *
At a glance
- Drugs Darvadstrocel (Primary)
- Indications Rectal fistula
- Focus Registrational; Therapeutic Use
- Sponsors Takeda
- 27 Mar 2019 Planned End Date changed from 30 Nov 2022 to 27 Nov 2020.
- 27 Mar 2019 Planned primary completion date changed from 9 May 2020 to 15 May 2020.
- 27 Mar 2019 Status changed from not yet recruiting to recruiting.